David Moatazedi - Mar 27, 2023 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role: President and Chief Executive Officer, Director
Signature: /s/ Jeffrey J. Plumer, as attorney-in-fact for David Moatazedi
Stock symbol: EOLS
Transactions as of: Mar 27, 2023
Transactions value $: -$51,752
Form type: 4
Date filed: 3/29/2023, 05:11 PM
Previous filing: Mar 16, 2023
Next filing: May 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EOLS	Common Stock	Sale	-$51.8K	-6.11K	-0.99%	$8.47	610K	Mar 27, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

Remarks:

President and Chief Executive Officer